Roche's Molecular Diagnostics, Applied Science Sales Rise in Q1 | GenomeWeb
NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales increased 4 percent and its applied science sales climbed 19 percent for the first quarter of 2008.
 
The Swiss pharmaceuticals, diagnostics, and life sciences research giant posted an overall decline in first-quarter sales of 4 percent, due to reduced demand for its influenza drug Tamiflu and the weaker US dollar. It reported revenues of 10.9 billion Swiss francs ($10.9 billion), down from CHF 11.4 million in the comparable period of 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.